Can a simple blood test spot cancer early? Here’s what we know – Firstpost

If you happen to’re feeling worn out or have all of the sudden misplaced some weight, your physician may ship you for a blood check.

Blood exams are a typical means health-care professionals detect, diagnose, and monitor a variety of medical circumstances.

However can they assist us detect extra severe circumstances akin to most cancers? Let’s dive into the analysis.

How do blood exams work?

Blood exams are a method used within the area of pathology, which is the examine of the character and causes of illness.

Blood exams
assess what cells, proteins, and molecules are current within the blood. Well being-care professionals use them to watch issues like organ well being, vitamin ranges, immune system perform, and the presence of some infections.

To check for
anaemia, for instance, you’d take a blood check and rely the variety of pink blood cells in that blood pattern. One other instance is blood sugar testing, which is used to measure the glucose ranges of a affected person with diabetes.

What can blood exams inform us about most cancers?

At the moment, we will’t reliably diagnose most cancers utilizing a blood check. One main cause is it’s usually tough to differentiate between most cancers cells and regular, wholesome cells. That is very true in the case of early-stage tumours.

However blood check outcomes may give us clues about whether or not sure cancers are current within the physique. So how do they do that?

1. By revealing abnormalities in your blood

Blood cancers will usually trigger clear adjustments within the quantity and sorts of cells within the bloodstream. We will measure these adjustments utilizing a
full blood rely, also referred to as a “full blood examination”.

One of these blood check counts all of the several types of cells current within the blood: pink blood cells, white blood cells, platelets, and extra.
Blood cancers come up when your physique produces an irregular quantity of any kind of blood cell. White blood cells, which battle an infection, are the commonest instance. So a excessive variety of a number of of those cell varieties might counsel the presence of a blood most cancers.

However full blood counts aren’t sufficient to make a conclusive prognosis of blood most cancers. We have to carry out different exams to substantiate whether or not the issue is a most cancers or a distinct illness. These exams might embrace a biopsy or imaging strategies akin to an MRI, CT scan, or X-ray.

2. By figuring out “tumour markers”

We will additionally use blood exams to detect particular proteins which most cancers cells usually produce in higher numbers. These proteins are often known as “tumour markers”.

One instance of a tumour marker is
prostate-specific antigen. This antigen is a protein made solely by the prostate gland. A wholesome male could have solely a small quantity of prostate-specific antigen in his blood. In distinction, a male with prostate most cancers will usually produce abnormally excessive ranges of this antigen. On this means, the prostate-specific antigen can function a “marker” of prostate most cancers.

There are lots of
totally different tumour markers used to determine totally different cancers. Nonetheless, measuring tumour markers isn’t a foolproof resolution. It is because they are often influenced by different elements. For instance, an harm to or irritation of the prostate gland might trigger prostate-specific antigen ranges to extend. So your physician might carry out extra exams to substantiate if an individual has most cancers.

3. By finding rogue cells

For different sorts of most cancers, blood exams can search for
circulating tumour cells. Circulating tumour cells are produced when most cancers cells break off from the unique tumour after which enter the bloodstream. This often solely occurs when a most cancers reaches a extra superior stage and is
metastatic, which means it has unfold to different elements of the physique.

However this kind of check is often prognostic, slightly than diagnostic. This implies we will solely use it to watch the development of a most cancers which has already been recognized. So if a blood check does determine circulating tumour cells, it’s best to conduct extra exams earlier than continuing with therapy.

So, are we near making a cancer-detecting blood check?

Sadly, we’re but to discover a strategy to detect most cancers with a single blood check. It’s a really tough job, however researchers are making progress.

Circulating tumour DNA is a present subject of curiosity. These DNA molecules have mutations which distinguish them from wholesome cells and may give details about the most cancers they got here from.

In a single
2025 trial, Australian researchers measured the quantity of circulating tumour DNA in 441 individuals with colon most cancers to find out which sufferers would reply to chemotherapy. One other
examine from 2025 used circulating tumour DNA to watch how 940 sufferers with lung most cancers responded to totally different therapies.

One check did declare to efficiently use circulating tumour DNA to detect greater than 50 sorts of early-stage most cancers. It’s often known as the “Galleri check” and was first trialled within the UK in 2021. Nonetheless, some consultants have since
raised considerations in regards to the check’s effectiveness.

Researchers are additionally exploring different methods of utilizing blood exams. In a single
2025 examine, Australian researchers tailored an current check to make use of blood as an alternative of tissue samples to
determine identified markers of ovarian most cancers.

One other Australian
examine from 2025 investigated whether or not molecules apart from proteins might function most cancers markers. It discovered sure fat in blood can point out if a affected person with superior prostate most cancers will
reply to therapy.

So, it seems like we’re nonetheless some time away from making a cancer-detecting blood check. However with a while, effort, and strong analysis, it could possibly be a chance.

John (Eddie) La Marca, Senior Analysis Officer, Blood Cells and Blood Most cancers, WEHI (Walter and Eliza Corridor Institute of Medical Analysis) ;
Cameron Lewis, Clinician Scientist, WEHI (Walter and Eliza Corridor Institute of Medical Analysis) , and
Sarah Diepstraten, Senior Analysis Officer, Blood Cells and Blood Most cancers Division, WEHI (Walter and Eliza Corridor Institute of Medical Analysis)

This text is republished from
The Dialog underneath a Artistic Commons license. Learn the
unique article.